REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Whole Live Micro-organism, Cell, Or Virus Containing > Bacteria Or Actinomycetales > Lactobacillus Or Pediococcus Or Leuconostoc Lactobacillus Or Pediococcus Or LeuconostocLactobacillus Or Pediococcus Or Leuconostoc patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/09/07 - 20070184039 - Process for the selective withdrawal of bacterial strains adhering to intestinal mucosa through endoscopy The present invention relates to a novel process for collecting and isolating bacterial strains adhered to the intestinal mucosa by the endoscopic route by means of an innovative technique called “brushing”. ... 08/02/07 - 20070178079 - Novel probiotics for pet food applications The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions containing the same. ... 08/02/07 - 20070178078 - Method for modifying gut flora in animals A method for enhancing the balance of beneficial and deleterious bacteria in the gastrointestinal tract of an animal having or at risk for inflammatory bowel disease (IBD) by administering to the animal a composition comprising at least one antioxidant, optionally in conjunction with one or more of a probiotic and ... 07/19/07 - 20070166294 - Method for reducing aflatoxins in fodders, meats, milk and derivatives thereof and a composition suitable for said purpose The invention relates to a method for reducing drastically and/or eliminating aflatoxins in feeds, thus enabling to produce meat and milk free from aflatoxins, by using specific lactic bacteria eliminating the presence of molds from feeds for cattle nutrition and the subsequent aflatoxin contamination of meats, milk and dairy products; ... 07/12/07 - 20070160589 - Probiotic food, process for its preparation and dietary regimen A probiotic food item containing a beneficial amount of dry active probiotic cultures is provided. The food item also contains a substantial continuous fat-based coating with an effectively low water activity level. The food item is packaged in a substantially moisture impermeable package marked with a use by or sell ... 06/28/07 - 20070148149 - Novel lactobacillus strains and uses thereof The invention concerns new isolated Lactobacillus cells, which are capable to aggregate Helicobacter pylori under culture conditions of the human digestive tract, in particular of the stomach, and to the uses of such cells. ... 06/28/07 - 20070148148 - Bacterial composition and its use The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is ... 06/28/07 - 20070148147 - Bacterial composition and its use The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is ... 06/28/07 - 20070148146 - Composition and method for inhibiting salmonella and campylobacter colonization in poultry One embodiment of the present invention is directed to the use of a novel competitive exclusion bacterial composition to prevent or reduce Salmonella or Campylobacter colonization in poultry. ... 06/21/07 - 20070141039 - Bifidobacterium in the treatment of inflammatory disease A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may ... 06/14/07 - 20070134220 - Lactobacillus fermentum strain and uses thereof The present invention concerns a new strain of Lactobacillus fermentum (LB-f) that is useful in preventing or treating gastrointestinal disorders in mammals, especially in humans. Also, this strain can be used as a dietary product that is beneficial to the wellbeing and health of mammals, including humans. ... 06/07/07 - 20070128178 - Probiotics for gut neuromuscular functions The present invention relates to the use of proboscis in nutritional compositions or medicaments for the prevention of treatment of gut-neuromuscular abnormalities. Such abnormalities are, for example, associated with colic in babies, gut-pain or gut discomfort in general. In particular, the invention relates to the prevention or treatment of gut ... 05/31/07 - 20070122398 - Encapsulated hydrophilic compounds The present invention relates to capsules for encapsulating functional agents, such as flavors, fragrances, pharmaceuticals, vitamins, etc. The capsules are suitable for the encapsulation of hydrophobic as well as hydrophilic substances. The capsules include a micro-organism, a matrix component and the encapsulatable material, wherein the latter comprises the functional agent ... 05/31/07 - 20070122397 - Probiotic storage and delivery Probiotic microorganisms are micro encapsulated by dispersing the probiotic microorganism in an aqueous suspension of a film forming protein and a carbohydrate; in an oil in water emulsion of a film forming protein and a carbohydrate and a fat; or in an oil which is subsequently dispersed in a film ... 05/24/07 - 20070116693 - Bacterial culture having effects of suppressing dermatitis development and accelerating skin wound healing, and product using the same A culture prepared by culturing a bacteria group separated from kefir grains and a new species Lactobacillus sp. SIID 1719-6b of the family Lactobacillaceae in the presence of green tea and then removing the bacterial cells from the resulting bacterial culture. ... 05/10/07 - 20070104700 - Nutritional formula for optimal gut barrier function The present invention pertains to a composition for inducing a pattern of gut barrier maturation similar to that observed with breast-feeding and able to improve gut barrier maturation, e.g. during neonatal stress. In particular, the present invention relates to an infant formula containing a combination of specific ingredients designed to ... 05/03/07 - 20070098705 - Probiotic composition comprising at least two lactic acid bacterial strains which are able to clonise the gatrointestonal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and fib In a probiotic composition comprising at least two specific lactic acid bacterial strains, the strains are able to colonize the gastrointestinal tract of humans and animals and have in combination at least two beneficial properties. The properties include an intestinal survival property, an intestinal binding property, an infection protecting property, ... 04/19/07 - 20070086991 - Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels A lactic composition containing at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus casei and a mixture of Lactobacillus acidophilus and Lactobacillus casei, and a whole broth of the bacterial strain or the mixture of the bacterial strains, is useful for the prevention or treatment ... 04/19/07 - 20070086990 - Table olives containing probiotic microorganisms The invention relates to table olives enriched with probiotic microorganisms, in particular lactobacilli and bifidobacteria, food products containing them and a method for their preparation. The olives and food products of the invention provide an amount of microorganisms sufficient to exert a beneficial action on the gastro-intestinal tract and are ... 04/05/07 - 20070077238 - Production of organic and inorganic selenium compounds by lactic acid bacteria A novel strain of lactic acid bacteria was found to be heat resistant and able to grow in a sulfur-limiting medium (SLM) containing a high concentration of sodium selenite. The microorganism is a non-spore forming and Gram-positive coccus, which is identified with >90% confidence using the API biochemical and sugar ... 03/29/07 - 20070071738 - Propionibacterium p-63 for use in direct fed microbials for animal feeds A ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of Propionibacterium P-63 is provided. Also disclosed is a process for reducing acidosis in ruminants or scours in swine by administration of the bacterium to the ruminant or swine. The microbial composition may be administered by ... 03/29/07 - 20070071737 - Live bacterium preparation containing lactic acid bacterium as active ingredient and food containing lactic acid bacterium Disclosed is a live bacterium preparation or food containing a lactic acid bacterium comprising a lactic acid bacterium, Lactobacillus salivarius, as an active ingredient. There is provided a live bacterium preparation and food containing a lactic acid bacterium that can prevent onset, recurrence and exacerbation of periodontal disease and/or dental ... 03/22/07 - 20070065423 - Antidiarrheal agent for livestock and poultry The present invention is to provide a safe antidiarrheal agent and a method for suppressing diarrhea by which an efficient antidiarrheal effect is achieved without using antibiotics or synthetic antibacterial agents that have been conventionally used against infections in livestock and poultry. Antibiotic-resistant pathogenic infections an also invented aid treated ... 03/15/07 - 20070059298 - Method for administering a vaginal care composition A vaginal care composition is introduced directly into the vagina in the form of an ovule, a cream or an ointment or with a tampon or which is brought into a position outside the vagina on a panty liner. The composition comprises viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, ... 03/15/07 - 20070059297 - Methods and compositions for improving visual acuity Compositions and methods for enhancing visual acuity in animals are disclosed. The compositions and methods utilize long chain polyunsaturated fatty acids. ... 03/15/07 - 20070059296 - Probiotic composition having acid-resistant enteric coating A probiotic composition essentially comprises 15 to 20 wt % of milk powder, 25 to 30 wt % of corn starch, 8 to 15 wt % of modified starch (capsul), 10 to 15 wt % of ethylcellulose, 5 to 15 wt % of bacterial broth, and 10 to 15 wt ... 03/15/07 - 20070059295 - Compositions and methods for the prevention and removal of biofilms on inert and biological surfaces Organisms, compositions, and methods for at least partially reducing the formation of a biofilm and/or at least partially removing a biofilm are provided. The organisms, compositions, and methods may be used on biotic and abiotic surfaces. ... 03/01/07 - 20070048295 - Method for preparing alginate capsules The present invention relates to a method for preparing alginate capsules, including incorporating at least one prebiotic and at least one pancreatic digested protein in the wall of an alginate capsule. The present invention also relates to the alginate capsules prepared by the method. ... 02/15/07 - 20070036776 - Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties This invention relates to composition and methods of employing said composition for treating or preventing microbial associated infections and diseases. More particularly the present invention relates to bacterial proteins, peptides and amino acids which are by-products of bacteria, in particular Lactobacillus and more specifically Lactobacillus strains GR-1 and RC-14, in ... 02/08/07 - 20070031393 - Methods of use of probiotic bifidobacteria for human beauty benefits Methods of use in humans of probiotic bacteria of the genus Bifidobacteria for regulating the condition of human keratinous tissue to achieve cosmetic beauty benefits. Said methods include regulation, either prophylactic or therapeutic, of the cosmetic appearance of human keratinous tissue, such as human hair, skin (e.g., scalp), and nails. ... 01/25/07 - 20070020250 - Lactic acid bacteria producing nisin at high concentration and method for selecting the same The present invention provides lactic acid bacteria producing Nisin, a method for selecting the same, and foods or feeds using the lactic acid bacteria. ... 01/25/07 - 20070020249 - Compositions for prevention and treatement of symptoms of gastrointestinal distress A composition for the treatment or prevention of gastro-intestinal distress associates with the consumption of food products containing sugar alcohols includes at least one enzyme, at least one probiotic organism and simethicone. The composition may be consumed immediately prior to but not more than 20 minutes prior to consuming a ... 01/11/07 - 20070009503 - Antibiotic, compositions containing the antibiotic, and methods for administering the antibiotic and/or said compositions to livestock An antibiotic comprising a protease-resistant bacteriocin derived from a lactic acid bacterium, and compositions thereof, are disclosed. A feed composition for livestock comprising the antibiotic comprising a protease-resistant bacteriocin derived from a lactic acid bacterium is also disclosed. A method for preventing the growth of human food poisoning-causing bacteria in ... 01/11/07 - 20070009502 - Nutritional conjunctive support therapy for recovery in animals following stress or illness A composition of probiotics, vitamins and minerals, electrolytes with glutamine and glucose along with medium chain triglycerides are provided as a supplement to animals. This is administered to cattle, calves, sheep, pigs, horses, dogs, and cats that are experiencing stress and or are undergoing medical drug therapy to treat conditions ... 12/28/06 - 20060292133 - Use of lactobacillus salivarius Lactobacillus salivarius is useful in the prophylaxis or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer. The Lactobacillus salivarius is of human origin isolated from resected and washed human gastrointestinal tract. ... 11/30/06 - 20060269534 - Feline probiotic bifidobacteria According to the invention there is provided a strain of lactic acid bacteria of the genus Bifidobacteria obtainable by isolation from resected and washed feline gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria of the present invention are also provided. ... 11/30/06 - 20060269533 - New strains of bifidobacterium having the ability to produce glutamine The invention refers to new strains of Bifidobacterium, especially of the species Bifidobacterium infantis, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains. ... 11/23/06 - 20060263344 - Novel probiotic compositions and methods of using the same The invention provides a soft, chewable confection obtained without using high heat or dehydration. In one embodiment, the confection contains an active ingredient which consists essentially of an effective amount of at least one probiotic organism. In another embodiment, the confection consists essentially of an effective amount of at least ... 11/16/06 - 20060257384 - Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains of Lactobacillus plantarum are a. ... 11/09/06 - 20060251636 - Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the ... 11/09/06 - 20060251635 - Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them Novel polynucleotides isolated from Lactobacillus rhamnosus, as well as probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed. ... 11/09/06 - 20060251634 - Method of improving immune function in mammals using lactobacillus strains with certain lipids A method of improving immune-function in mammals using selected 3-HPA producing lactic acid bacteria with a medium chain triglyceride (MCT) oil. ... 11/09/06 - 20060251633 - Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations The present invention relates to dietetic and/or pharmaceutical compositions for human and/or animal use, and general foodstuffs, based on microbial cultures consisting of autochthonous and allochthonous species with respect to human beings and animals, selected from species of lactic bacteria, propionibacteria, yeasts and/or molds. They have an equilibrating action of ... 11/02/06 - 20060246045 - Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concertration Disclosed is a method of manipulating the rate of gastrointestinal transit in a mammalian subject Also disclosed is the use, in the manufacture of a medicamens for the treatment of constipation, of a selective inhibitor of methanogensis, a methanogen-displacing probiotic agent, or a prebiotic agent that inhibits the growth of ... 10/19/06 - 20060233774 - Composition for the improvement of liver function, the reduction of serum ethanol level and antioxidant activity enhancement The present invention is directed to a composition for use in liver function improvement, blood alcohol level reduction and in-vivo antioxidant activity enhancement, comprising Lactobacillus brevis HY7401, Lactobacillus fermentum CS332, Lactobacillus acidophilus CSG, Bifidobacterium longum HY8001, an Alder tree extract, a Selfheal extract, a milk thistle extract, a green bean-rice ... 10/19/06 - 20060233773 - Method for preventing or treating the development of respiratory allergies The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG. ... 10/19/06 - 20060233772 - Method for preventing or treating the development of respiratory allergies The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG. ... 09/21/06 - 20060210545 - Process for treating spirulina The treatment of spirulina by a process which includes placing spirulina that has not been previously heat-sterilized, lactic acid bacteria and sugar in water, then culturing the lactic acid bacteria provides treated spirulina in which the distinctive taste and odor of spirulina are minimized, in which active ingredients such as ... 09/14/06 - 20060204485 - Probiotics in the treatment of atypical depression and other disorders characterised by hypothalamic pitiuitary-ardrenal axis over activity A method of treating a disorder characterized by hypothalamic-pituitary-adrenal axis over-activity comprising administering to a subject a probiotic bacterium. ... 09/14/06 - 20060204484 - Storage stable frozen lactic acid bacteria culture A storage stable frozen lactic acid bacteria (LAB) culture that comprises LAB that are that are able to utilize sucrose, has a weight of at least 50 g frozen material and a content of viable bacteria of at least 109 colony forming units (CFU) per g frozen material. ... 08/31/06 - 20060193842 - Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life Disclosed is a formulation for preserving the life of probiotic bacteria during passage through the stomach, while permitting their release in the intestine, and which has a low water activity and correspondingly long shelf life. These formulations are designed to retain potency up to the product expiration date. The formulation ... 08/17/06 - 20060182727 - Lactic acid bacteria capable of stimulating mucosal immunity The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimulating mucosal immunity, and more specifically, the compositions in the form of foods or beverages or pharmaceutical ... 08/03/06 - 20060171936 - Cosmetic and/or dermatological composition for sensitive skin The present invention relates to the use of an effective amount of at least one microorganism belonging to the species Lactobacillus paracasei or casei, a fraction thereof or a metabolite thereof, in combination with an effective amount of at least one microorganism belonging to the species Bifidobacterium longum or Bifidobacterium ... 07/27/06 - 20060165670 - Synbiotic combination The invention concerns a composition comprising a Lactobacillus strain and a non-digestible oligosaccaride. ... 07/27/06 - 20060165669 - Lactobacillus iners for the enhancement of urogenital health The present invention provides methods and compositions for administration of Lactobacillus iners alone or together with at least one other probiotic organism such as Bifordobacterium, or another Lactobacillus for reduction of the risk of urogenital infection and concomitant restoration and/or maintenance of a healthy urogenital flora. A method of treatment ... 07/13/06 - 20060153822 - Alcohol-tolerant malolactic strains for the maturation of wines with average or high ph Lactic bacterial strains of the genera Lactobacillus and Pediococcus which are capable of initiating and carrying out a complete malolactic fermentation on direct introduction, in the dried, frozen or lyophilised state, without a previous acclimatization step, at a concentration of between 106 and 5×107 UFC/ml, into a wine with an ... 06/22/06 - 20060134083 - Compositions comprising sclareol or derivatives thereof and uses thereof The present invention provides a composition which includes a sclareol or a derivative thereof, wherein the sclareol or a derivative thereof is bound by a glycoprotein matrix. The composition of the invention provides improved potency, stability and bioactivity characteristics of sclareol, or its derivatives. ... 06/22/06 - 20060134082 - Mammalian animal compositon The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Camplylobacter infection in a mammalian animal. It also relates to a method for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian animal, the method ... 06/15/06 - 20060127380 - Lactobacillus casei bd-ii stain and used to reduce blood cholesterol The invention disclosed a kind of lactobacillus casei Bd-II, the accession number of the deposit of which is CGMCC NO. 0849, and also disclosed a use of it for reducing blood lipid level. ... 06/15/06 - 20060127379 - Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof This invention relates to lactic fermenting products of ginseng obtained by fermentation of ginseng using lactic acid bacteria, yoghurt containing said lactic fermenting products of ginseng, and lactic acid bacteria used in the preparation of said lactic fermenting products of ginseng. ... 06/15/06 - 20060127378 - Composition for promoting the proliferation of lactobacillus casei subsp. casei The present invention relates to a composition for promoting bacterial proliferation for selectively proliferating Lactobacillus casei subsp. casei, which includes a dextran. According to the present invention, a variety of biological activities originated from L. casei subsp. casei can be sustained in a living body by selectively growing-proliferating and colonizing ... 06/08/06 - 20060121015 - Probiotic bifidobacterium strains A Bifidobacterium strain, AH208, AH209, AH210, AH211, AH212 or AH214 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome. ... 05/18/06 - 20060104965 - Method for increasing lactose tolerance in mammals exhibiting lactose intolerance The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing product over a six week period. At various points during the six week period the subject ingests the lactose containing product once a day ... 05/11/06 - 20060099196 - Photoprotective orally administrable composition for skin An orally administrable composition for the photoprotection of the skin which comprises a photoprotecting effective amount of i) at least one probiotic lactic acid bacterium or a culture supernatant thereof, and ii) at least one yeast, included into an orally acceptable carrier. ... 05/04/06 - 20060093594 - Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions A method of preparing an ultra-cleansed lactoferrin preparation, termed treatment for contaminant reduction (TCR) is provided which includes the steps of treating commercial lactoferrin preparation with at least one each of surfactants, antioxidants and polyphenols to form purified lactoferrin (LF-TCR) and drying the LF-TCR. Additionally a therapeutic lactoferrin composition is ... 05/04/06 - 20060093593 - Pro-biotic broad-spectrum nourishment preparation in powder, liquid, paste, or gas form A pro-biotic broad-spectrum nourishment preparation for employment as a food additive. The preparation provides an improvement of extraction in the nourishment of animals and the increase of immunity against diseases when consumed by animals in their food. Favored formulas employ a number of food additives including one or a combination ... 05/04/06 - 20060093592 - Synbiotics A novel product comprising a mixture of probiotic and prebiotic ingredients for the treatment of IBS, IBD, Crohn's disease, antibiotic induced diarrhea and other bowel disorders is described herein. Stabilized rice bran derivatives, including stabilized rice bran, RiSolubles, RiceMucil, and Cea100, are used as the source of prebiotics. The prebiotic ... 05/04/06 - 20060093591 - Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions The invention describes therapeutic compositions including a lactic acid-producing bacteria, such as isolated Bacillus coagulans, in combination with a bifidogenic oligosaccharides or other cholesterol-reducing agents for use in reducing LDL cholesterol and serum triglycerides. Also described are therapeutic methods using the compositions and systems containing the therapeutic compositions. ... 04/27/06 - 20060088514 - Formulation comprising a bacterial strain An injectable formulation of a bacterial strain such as a Lactobacillus salivarius strain is useful in treating of inflammatory disorders such as colitis or arthritis. ... 04/27/06 - 20060088513 - Antiallergic composition As for means for solving the object, it is to provide an antiallergic composition comprising as active ingredients the lactic acid bacteria showing equal interleukin 12 production level compared to when Lactobacillus paracasei KW 3110 strain is used as the lactic acid bacteria to be tested, or showing 60% or ... 04/20/06 - 20060083724 - Compositions for the treatment of femal sexual dysfunction The compositions and methods disclosed herein are of use for the treatment of female sexual dysfunction. The disclosed compositions and methods pertain to topical formulations including at least three vasodilating agents that act by different physiological pathways, and at least one sensory or functional additive. ... 04/20/06 - 20060083723 - Novel microorganism strain gm-090 of lactobacillus fermentum and its use for stimulating ifn-y secretion and/or treating allergy The present invention provides an isolated microorganism strain, Lactobacillus fermentum GM-090, which is found to be effective in stimulating IFN-γ secretion and/or treating allergy. The use of the Lactobacillus fermentum GM-090 in stimulating IFN-γ secretion and/or treating allergy is also provided. ... 04/13/06 - 20060078548 - Microorganisms having intestinal cell surface glycosylation modulating action The invention concerns micro-organism strains, in particular of lactic acid bacteria, having a glycosylation modulating effect of intestinal cell surface. The invention also concerns a method for selecting micro-organism strains, in particular of lactic acid bacteria, which consists in measuring the average fluorescence intensity variation of HT29-MTX cells incubated in ... 04/13/06 - 20060078547 - Probiotic lactobacillus salivarius strains A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome. ... 04/13/06 - 20060078546 - Use of lactic acid bacteria to reduce sick time A method of decreasing sick time, and thus sick-leave, in which selected strains of lactic acid bacteria are administered. ... 04/06/06 - 20060073129 - Composition and method for inhibition of microorganisms A composition and method for the inhibition of microorganisms. ... 03/30/06 - 20060067924 - Probiotic bacteria and methods Provided herein are molecular methods for assessing the state of gastrointestinal microflora of an animal, especially a species of poultry, and methods for identifying probiotic bacteria by comparing certain bacteria present in animals fed a diet not containing antibiotics but absent or present in significantly lower numbers in animals fed ... 03/30/06 - 20060067923 - Preventing agent against drug-resistant bacterial infection By using lactic acid bacteria, their dead bacteria or treated substances thereof, or Mygasphaera elsdenii as active components, for an agent for preventing and treating drug-resistant bacterial infection for livestock/fowls or fish and shellfish carrying or being infected by drug-resistant bacteria such as Vancomycin, particularly by using Enterococcus faecalis, Enterococcus ... 03/30/06 - 20060067922 - Low water activity nutritional product having beneficial microbial and high oil content The present invention relates to a composition for the oral administration of beneficial microorganisms in a discrete dosage form, comprising about 10% to about 50% by weight of a starch component, about 25% to about 50% by weight of a sugar component, about 0-20% of a humectant component, and about ... 03/30/06 - 20060067921 - Probiotic bacterium: lactobacillus fermentum Variant of the bacterium Lactobacillus fermentum and its use in treating gastrointestinal disorders, disorders of the mucosal surfaces or disturbances in the immune system or status of a subject. ... 03/23/06 - 20060062774 - Compositions for maintaining and restoring normal urogenital flora A composition and methods for maintaining and restoring normal urogenital flora in humans. The composition includes one or more bacteria selected from the group consisting of Lactobacillus iners, all clones with at least 97% sequence similarity to Lactobacillus iners, Atopobium spp, and all clones with at least 90% sequence similarity ... 03/23/06 - 20060062773 - Compositions for maintaining and restoring normal gastrointestinal flora A composition and method for maintaining and restoring normal gastrointestinal flora in humans. The composition includes one or more bacteria selected from the group consisting of Lactobacillus iners, all clones with at least 97% sequence similarity to Lactobacillus iners, Atopobium spp, and all clones with at least 90% sequence similarity ... 03/16/06 - 20060057132 - Identifying and treating vaginal infections The presence of a vaginal affection is determined in a subject using an identifiable indicator and, if the indication is positive, a gynecological composition comprising one or more Lactobacillus strains is administered locally in an amount effective to treat the vaginal affection. Also described are packages or kits including a ... 03/16/06 - 20060057131 - Malleable protein matrix and uses thereof The present invention relates to a malleable protein matrice (MPM), which is the reaction product of the agglomeration of proteins after a fermentation process and is exhibiting biological activities and is suitable for the incorporation (or encapsulation) of various hydrophilic or lipophylic substances. The present invention also relates to the ... 02/16/06 - 20060034814 - Probiotic bacteria Strains of pro-biotic bacteria, their isolation, characteristics and methods of use to prevent or treat carriage by a food production animal of Salmonella that causes human salmonellosis are provided. Methods for isolating and characterizing the probiotic bacteria are also provided. The present invention further provides methods for using the probiotic ... 02/09/06 - 20060029585 - Methods for reducing morbidity Various compositions containing transfer factor in combination with nutraceuticals are provided including transfer factor in combination with zinc and essential fatty acids and transfer factor in combination with lactic acid generating bacteria. Also provided are methods for treating animal diseases and syndromes using these compositions. ... 01/26/06 - 20060018890 - Method for preventing or treating respiratory infections and acute otitis media in infants The present invention is directed to a novel method for preventing or treating respiratory infections and acute otitis media in infants. The method comprises the administration of a therapeutically effective amount of a Bifidobacteria strain and an adherence-promoting probiotic, such as LGG, to the infant. ... 01/19/06 - 20060013806 - Probiotics in primary prevention of atopic diseases The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the healthy gut flora, pre- and postnatally to children at high risk of atopic diseases. ... 01/12/06 - 20060008453 - Methods and compositions for preventing and treating sensitive and dry skin Compositions for preventing and/or treating sensitive and/or dry skin include at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation, wherein the at least one agent includes at least one member selected from the group consisting of ... 01/05/06 - 20060002910 - Agent for the anti-adhesion of skin pathogenic flora Bacterial agents for preparing compositions which are for cosmetic, pharmaceutical or veterinary use and which are intended to stabilize and/or regulate the cutaneous ecosystem of mammals. These bacterial agents are extracts of a bacterium, or a bacterium and are selected for their adhesion to skin cells and anti-adhesion to pathogens ... 01/05/06 - 20060002909 - Microorganism separated from kefir grains, a microorganism culture obtained by culturing said microorganism or microorganisms including it, and a product using such microorganisms or microorganism cultures A single or mixed culture performed under conditions in which a new species of the Lactobacillaceae family having antioxidant properties and separated from Kefir grains can be cultured. An antioxidant having the obtained culture or bacteria as active principles is formulated and used as a raw material for or added ... 01/05/06 - 20060002908 - Bifidobacterium in the treatment of inflammatory disease A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may ... 01/05/06 - 20060002907 - Method of improving immune function in mamals using lactobacillus reuteri strains The invention herein is related to the use of Lactobacillus reuteri strains as immune enhancing agents, methods of improving immune-function in mammals using Lactobacillus reuteri strains in products containing cells of such strains and the products as such. These strains exhibit good toxin binding and neutralizing effect, and exhibit good ... 12/22/05 - 20050281792 - Phytases, nucleic acids encoding them and methods of making and using them In one aspect, the invention provides a purified and modified phytase enzyme from Escherichia coli K12 appA phytase. The enzyme has phytase activity and improved thermal tolerance as compared with the wild-type enzyme. In addition, the enzyme has improved protease stability at low pH. Glycosylation of the modified phytase provided ... 12/08/05 - 20050271641 - Method for improved breast milk feeding to reduce the risk of allergy Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause ... 12/08/05 - 20050271640 - Method for inhibiting yeast growth The invention relates to the use of microbes Lactobacillus rhamnosus LGG, ATCC 53103, Latobacillus rhamnosus LC705, DSM 7061, and Propionibacterium freudenreichii ssp. shermanii PJS, DSM 7067 in inhibiting yeast growth, for preventing and treating diseases caused by yeast and for relieving yeast-related symptoms in animals or humans. ... 12/01/05 - 20050265984 - Composition having immunoregulating activities The invention provides a composition comprising novel lactic acid bacteria having immunoregulating activities. Specifically, the invention provides food, drinks or medicaments containing novel lactic acid bacteria separated from “Shibazuke,” one kind of traditional Kyoto pickles, and having immunoregulating activities. The lactic acid bacteria belong to Lactobacillus pentosus and have a ... 11/24/05 - 20050260181 - Compositions and methods for tissue repair This invention relates to a composition and method for treating diseased or damaged tissues. The composition provides anabolic components and other components that mimic conditions of healthy human tissue, promote tissue regeneration and alleviate disease states. The composition is a medicament having a first component comprising a plurality of L ... 11/03/05 - 20050244392 - Probiotic strains, a process for the selection of them, compositions thereof, and their use The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pathogenic strains which are able to be transferred to breast ... 11/03/05 - 20050244391 - Compositions and methods for inhibiting pathogenic growth The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an ... 11/03/05 - 20050244390 - Compositions and methods for inhibiting pathogenic growth The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an ... 11/03/05 - 20050244389 - Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine. ... 10/27/05 - 20050238631 - Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria Disclosed herein are compositions and methods for preventing biofilm formation, reducing existing biofilm, and/or reducing populations of pathogenic, indicator, and spoilage bacteria. In one example, disclosed are cell-free fermentates using Lactobacillus species, Pediococcus species, and/or Lactococcus species used separately, in combination, or combined with extract from Delisea pulchra marine algae. ... 10/27/05 - 20050238630 - Compositions and methods for inhibiting pathogenic growth The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an ... 10/20/05 - 20050232910 - Anti-listeria bacteriocin The invention concerns an isolated polypeptide which is a bacteriocin called Sakacin G derived from Lactobacillus sakei 2512. The invention also concerns a nucleic acid molecule encoding for said bacteriocin and the use of said polypeptide as an active agent against pathogenic and undesirable flora in the preparation of food ... 10/20/05 - 20050232909 - Inhibition of pathogens by probiotic bacteria Compositions containing a lactic acid-producing bacterial strain, e.g., Bacillus coagulans for inhibition of pathogenic bacterial infections. Spores or extracellular products produced by the bacterial strains are also useful as inhibitory agents. ... 10/20/05 - 20050232908 - Novel use of the extract of processed ginseng and saponin isolated therefrom The present invention relates to novel use of the extract of processed ginseng extract having brain stroke protecting or treating activity. More particularly, the present invention relates to a processed ginseng extract with enhanced pharmacological effects due to subsequent treatment i.e., acid-treatment of ginseng and bio-converting treatment such as lactic ... 10/06/05 - 20050220777 - Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae A method of selection of lactic acid bacteria for providing a method of protecting humans against Streptococcus pneumoniae infections by selecting a lactic acid bacterial strain (LAB) naturally carrying genes coding for proteins similar to the PspC, choline binding protein of S. pneumoniae so that the selected LAB can be ... 10/06/05 - 20050220776 - Lactobacillus strains Novel Lactobacilli strains, Lactobacillus acidophilus strain Lba EB01 (Lba EB01), Lactobacillus paracasei strain Lbp PB01 (Lbp, PB01), Lactobacillus acidophilus strain Lba EB02, Lactobacillus plantarum strain Lbpl PB02, Lactobacillus strain Lbxx EB03 and Lactobacillus strain Lbxx PB03, and strains with essentially the same advantageous properties which alone or in combination can ... 09/29/05 - 20050214273 - Propionibacterium p-63 for use in direct fed microbials for animal feeds A ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of Propionibacterium P-63 is provided. Also disclosed is a process for reducing acidosis in ruminants or scours in swine by administration of the bacterium to the ruminant or swine. The microbial composition may be administered by ... 09/29/05 - 20050214272 - Bifidobacterium in the treatment of inflammatory disease A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may ... 09/29/05 - 20050214271 - Lactobacillus paracasei strain gm-080 for treating allergy related diseases The present invention provides an isolated microorganism strain, Lactobacillus paracasei GM-080, which is found to be effective in treating allergy. The use of the Lactobacillus paracasei GM-080 in treating allergy related disease is also provided. ... 09/29/05 - 20050214270 - Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy The present invention provides an antiallergic agent containing, as an active ingredient, lactic acid bacteria selected from the group consisting of lactic acid bacteria of the species Lactobacillus acidophilus, Lactobacillus fermentum, and combinations thereof. The antiallergic agent is capable of improving allergic diathesis by reducing the IgE level, which is ... 09/22/05 - 20050208035 - Nutritional composition for treating an immune condition A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper, zinc, selenium, fructo-oligosaccharides and/or gum acacia, a probiotic lactic acid bacterium. For example, in an embodiment it comprises per 300 g: ... 09/22/05 - 20050208034 - Natural vaginal yeast infection control A nonprescription natural source to curing, preventing, controlling and managing vaginal yeast infections. This natural solution is available in tablet, capsule or powder formulation comprised of pure, natural, safe ingredients. This invention is ingested orally. ... 09/22/05 - 20050208033 - Lactic acid bacteria and their use for treating and preventing cancer The invention concerns the isolation of novel properties of lactic acid bacteria stains. Said novel properties are advantageously useful for preventing and treating cancer. More particularly, the invention concerns the use of lactic acid bacteria to facilitate induction of cell apoptosis of a cancer. The invention also concerns the use ... 09/15/05 - 20050201997 - Dioxin elimination promoter An accelerating agent for elimination of dioxins which comprises, as an active ingredient, a microorganism having an activity of accelerating elimination of dioxins in the body to the outside of the body. ... 09/15/05 - 20050201996 - Compositions and methods for treatment of skin disorders The present invention concerns methods and compositions for prophylactic or therapeutic treatment of skin disorders by administering therapeutically or prophylactically effective amounts of a probiotic. The present invention is also concerned with the treatment of symptoms of skin disorders. ... 09/08/05 - 20050196388 - Mutant lactobacillus bulgaricus strains free from beta-galactosidase activity The invention concerns mutant L. bulgaricus strains bearing a nonsense mutation, in at least one of the sequences coding for the lactose operon, and free from β-galactosidase activity, and lactic starters comprising these strains. The strains and starters can be used to obtain fermented milk products from glucose-added milk. ... 08/25/05 - 20050186191 - Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis, for the preparation of an ingestible carrier for the treatment and/or prophylaxis of disorders associated with the colonization of the gut by Giardia ... 08/25/05 - 20050186190 - Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product The invention relates to a composition which, depending on the user, may be taken as a nutritional, dietetic or strictly therapeutic preparation, comprising as its active substance alkaline sphingomyelinase which is capable of preventing or treating various pathological conditions including cancerous processes, inflammatory processes of the intestine, hypercholesterolaemia and infections ... 08/25/05 - 20050186189 - Novel microorganism strain gm-020 of lactobacillus rhamnosus and its use for treating obesity The present invention provides an isolated microorganism strain, Lactobacillus rhamnosus GM-020, which is found to be effective in treating obesity and a complication thereof. The use of the Lactobacillus rhamnosus GM-020 in treating obesity and a complication thereof is also provided. ... 08/25/05 - 20050186188 - Compositions containing probiotics and polysaccharides and methods of use Compositions and methods are provided for improving GI tract health by reducing the level of pathogenic bacteria present. The compositions comprise probiotic microorganisms, such as a lactic acid producing bacteria or a yeast and mannanoligosaccharide. Optionally, the compositions may further comprise fructooligosaccharide. Methods for administering the composition to improve GI ... 08/18/05 - 20050180963 - Probiotic propionibacterium The present invention relates to probiotic Propionibacterium strains and their use in the preparation of probiotic supplements and foods. The invention relates to the provision of Vitamin B12, propionic acid, folacin and bacteriocins by probiotic strains, stimulation of bifidobacteria growth, production of favourable effects on the lipid metabolism and on ... 08/18/05 - 20050180962 - Inactivated probiotic bacteria and methods of use thereof The present invention provides formulations comprising inactivated probiotic bacteria, and treatment methods using the formulations. ... 08/18/05 - 20050180961 - Probiotics and oral tolerance The invention refers to food products comprising at least a mean to promote the oral tolerance phenomenon (Lactobacillus paracasei), to food products comprising at least a mean to maintain the oral tolerance phenomenon (Bifidobacterium lactis), and to food products comprising means to promote and maintain the oral tolerance phenomenon (combination ... 08/11/05 - 20050175598 - Methods of use of probiotic bifidobacteria for companion animals According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria. ... 08/11/05 - 20050175597 - Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment The invention relates t a method of improving the viability of a labile bioactive substance on administration to a hostile environment, the method comprising forming a mixture of the bioactive substance and mammalian colostrum and also a composition for administration of a labile bioactive substance the composition comprising a mixture ... 08/04/05 - 20050169901 - Composition and methods afor diagnosis and treatment of cardiovascular disorders The present invention relates to methods for diagnosis, prevention and treatment of cardiovascular disorders or associated disorders and, in particular, to the use in such methods of regulating cytokine levels or activity. Compositions and kits suitable for use in the methods are described. ... 07/28/05 - 20050163764 - Treatment with agonists of toll-like receptors Mammals are treated with agonists of bacterially-activated TLRs. The agonist are administered orally or mucosally. In one embodiment, the mammal treated is subject to a gastro-intestinal injury. The agonist can be administered prior to infliction of the gastro-intestinal injury, subsequent to infliction of the gastro-intestinal injury and concurrently with infliction ... 07/21/05 - 20050158294 - Canine probiotic bifidobacteria pseudolongum According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided. ... 07/21/05 - 20050158293 - Canine probiotic lactobacilli According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided. ... 07/21/05 - 20050158292 - Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same To provide a microorganism and an ingredient thereof that contribute to prevention and treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer), a method of effectively selecting the microorganism, and a method of efficiently inducing immunoregulatory cells that play an important role on maintaining ... 07/21/05 - 20050158291 - Pet food composition for skin photoprotection An ingestable composition for the photoprotection of the skin of pets which comprises a photoprotecting effective amount of i) at least one probiotic lactic acid bacterium or a culture supernatant thereof, and ii) at least one yeast and/or a carotenoid or derivative, included into an ingestable carrier. ... 07/21/05 - 20050158290 - Process for the preparation of a nutrient formulation The present invention relates to a process for increasing the efficacy and/or bioavailability of a nutrient formulation or composition for the treatment and/or prevention of inflammatory processes associated with airway diseases such as asthma. In particular, the invention relates to a method of treating an airway disease in a subject ... 07/14/05 - 20050152885 - Colorectal neoplasia prophylaxis Development of colorectal neoplasia in a patient subject or predisposed to colorectal neoplasia is reduced by the steps of (a) determining a patient is subject or predisposed to colorectal neoplasia; and (b) enterically delivering into the gut of the person an effective amount of an aminoglycoside antibiotic having poor gut ... 07/14/05 - 20050152884 - Canine probiotic bifidobacteria globosum According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided. ... 06/09/05 - 20050123527 - Dried biotherapeutic composition, uses, and device and methods for administration thereof A biotherapeutic composition containing rapidly activatable bacteria in a dry form, a device for administering such a composition and methods of treatment thereof are disclosed. A method for preparing the biotherapeutic composition itself, as well as a method for preparing the bacteria for such a composition is also disclosed. ... ### FreshPatents.com Support |